Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the “Global Antisense Oligonucleotide Therapeutics Market- by Therapy (Monotherapy and Combination), Molecule Target Indication (DNA Molecule and RNA Molecule), Target Indication (Duchenne Muscular Atrophy, Spinal Muscular Atrophy, Familial Chylomicronemia Syndrome, Amyotrophic Lateral Sclerosis, Familial Partial Lipodystrophy, Hereditary Transthyretin-Mediated (hatter) Amyloidosis, Huntington’s Disease and Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”
According to the latest research by Insight Analytics, the global Antisense Oligonucleotide Therapeutics Market Size is valued at USD 2.2 Billion in 2024 and is predicted to reach USD 9.1 Billion by the year 2034 at a 15.3% CAGR during the forecast period for 2025-2034.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1245
Single-stranded, brief molecules of DNA or RNA make up antisense oligonucleotides. Antisense oligonucleotides function at the level of messenger RNA in the cell before proteins are created, but they do not alter the activity of proteins that have already been formed. Antisense oligonucleotides treat diabetes, asthma, hair loss, inflammation, and the central nervous system. In genomics, antisense oligonucleotides are also employed.
The market is linked to increasing consumer acceptance of antisense drugs, rising financing for research and development, neurological illnesses, and an aging population. The Food and Drug Administration (FDA) has granted numerous regulatory licenses for using novel antisense oligonucleotides pharmaceuticals, which will be advantageous for the antisense oligonucleotides industry.
Over the years, Europe is anticipated to contribute to the Antisense Oligonucleotide Therapeutics market. This is a result of the increasing acceptance of innovative antisense oligonucleotide drugs in the area. Key European companies are concentrating on strategic mergers and acquisitions and improving their antisense oligonucleotide product offerings. In addition, the North American Antisense Oligonucleotide Therapeutics market is expected to grow significantly during the forecast period.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1245
Major market players operating in the Antisense Oligonucleotide Therapeutics market include Pharmaceuticals, Inc., Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Inc., Antisense Therapeutics Limited, Sarna Therapeutics GmbH, Arrowhead Pharmaceuticals, Inc., Atlantic Pharmaceuticals, Inc., GlaxoSmithKline plc, Gerona Corporation, Gradualist, ICO Therapeutics, Aptos Biosciences, Enzo Pharmaceuticals, Inc., Bio-Path Holdings, Inc., Gene Signal International SA, Marina Biotech, mirage Therapeutics, Inc., Synodic, Inc., Oncogene Pharmaceuticals Inc., Pharm axis Ltd, Regulus Therapeutics Inc., Reran Pharmaceuticals, Inc., and RI Pharmaceuticals, among others.
Recent collaborations and agreements in the market:
- In January 2021, MilliporeSigma (US) acquired AmpTec, a well-known German business specializing in contract development and manufacturing mRNA (CDMO).
- In August 2019, Integrated DNA Technology released tools- oligo pools, a set of 350-nucleotide-long, high-quality DNA oligonucleotides (US).
Get Specific Chapter/Information From The Report:@
https://www.insightaceanalytic.com/customisation/1245
Market Segments
Global Antisense Oligonucleotide Therapeutics Market, by Therapy, 2025-2034 (Value US$ Mn)
- Monotherapy
- Combination
Global Antisense Oligonucleotide Therapeutics Market, by Molecule Target Indication, 2025-2034 (Value US$ Mn)
- DNA Molecule
- RNA Molecule
Global Antisense Oligonucleotide Therapeutics Market, by Target Indication, 2025-2034 (Value US$ Mn)
- Duchenne Muscular Atrophy
- Spinal Muscular Atrophy
- Familial Chylomicronemia Syndrome
- Amyotrophic Lateral Sclerosis
- Familial Partial Lipodystrophy
- Hereditary Transthyretin-Mediated (hatter) Amyloidosis
- Huntington’s Disease
- Others
Global Antisense Oligonucleotide Therapeutics Market, by Region, 2025-2034 (Value US$ Mn)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America Antisense Oligonucleotide Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- S.
- Canada
Europe Antisense Oligonucleotide Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific Antisense Oligonucleotide Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America Antisense Oligonucleotide Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa Antisense Oligonucleotide Therapeutics Market, by Country, 2025-2034 (Value US$ Mn)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Get More Information :
https://www.insightaceanalytic.com/report/global-antisense-oligonucleotide-therapeutics-market/1245
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
